OPKO Health (OPK) News Today $1.27 -0.01 (-0.78%) Closing price 04:00 PM EasternExtended Trading$1.26 -0.01 (-0.79%) As of 06:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock OPK Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2026 April 2026 March 2026 February 2026 January 2026 December 2025 November 2025 October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 Time Period Here's Why You Should Retain OPK Stock in Your Portfolio for NowMay 21 at 6:02 PM | finance.yahoo.comContrasting OPKO Health (NASDAQ:OPK) & NexGel (NASDAQ:NXGL)May 19 at 2:07 AM | americanbankingnews.comHead to Head Analysis: Mesa Laboratories (NASDAQ:MLAB) & OPKO Health (NASDAQ:OPK)May 18, 2026 | americanbankingnews.comOPKO Health (OPK) price target increased by 11.18% to 3.86May 14, 2026 | msn.comContrasting OPKO Health (NASDAQ:OPK) & DexCom (NASDAQ:DXCM)May 13, 2026 | americanbankingnews.comOPKO Health’s ModeX Therapeutics Will Present Data Demonstrating In Vivo CAR-T Cell Generation and Deep B-Cell Depletion in Preclinical StudiesMay 12, 2026 | finance.yahoo.comOPKO Health's ModeX Therapeutics Will Present Data Demonstrating In Vivo CAR-T Cell Generation and Deep B-Cell Depletion in Preclinical StudiesMay 12, 2026 | globenewswire.comSpotlight On Promising Penny Stocks For May 2026May 11, 2026 | finance.yahoo.comEntera Announces First Quarter 2026 Financial Results and Updates Across its Oral Peptide ProgramsMay 8, 2026 | finance.yahoo.comOPKO Health, Inc. (NASDAQ:OPK) Given Consensus Recommendation of "Hold" by BrokeragesMay 6, 2026 | marketbeat.comHC Wainwright Boosts Earnings Estimates for OPKO HealthMay 1, 2026 | marketbeat.comBarrington Research downgrades OPKO Health (OPK)April 30, 2026 | msn.comBioReference® Launches BioReference Direct™, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital PlatformApril 30, 2026 | finance.yahoo.comOPKO Health Expands Nicoya Agreement to Support RAYALDEE® Commercialization in Greater ChinaApril 30, 2026 | finance.yahoo.comOPKO Health Expands Nicoya Agreement to Support RAYALDEE® Commercialization in Greater ChinaApril 30, 2026 | globenewswire.comQ1 Earnings Estimate for OPKO Health Issued By HC WainwrightApril 30, 2026 | marketbeat.comBioReference® Launches BioReference Direct™, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital PlatformApril 30, 2026 | globenewswire.comOPKO Health, Inc.: OPKO Health Reports First Quarter 2026 Business Highlights and Financial ResultsApril 29, 2026 | finanznachrichten.deOPKO Health Q1 Earnings In-Line on Product Gains, Revenues Down Y/YApril 29, 2026 | finance.yahoo.comOPKO Health (NASDAQ:OPK) Hits New 1-Year Low - Should You Sell?April 29, 2026 | marketbeat.comOPKO Health (NASDAQ:OPK) Downgraded to "Market Perform" Rating by Barrington ResearchApril 29, 2026 | marketbeat.comOpko outlines Q2 2026 revenue of $127M-$132M as ModeX advances 5 clinical programsApril 28, 2026 | seekingalpha.comOPKO Health, Inc. (OPK) Q1 2026 Earnings Call TranscriptApril 28, 2026 | seekingalpha.comOPKO Health Q1 Earnings Call HighlightsApril 28, 2026 | marketbeat.comOPKO Health Reports First Quarter 2026 Business Highlights and Financial ResultsApril 28, 2026 | finance.yahoo.comOPKO Health (NASDAQ:OPK) Announces Quarterly Earnings Results, Hits EstimatesApril 28, 2026 | marketbeat.comOPKO Health Reports First Quarter 2026 Business Highlights and Financial ResultsApril 28, 2026 | globenewswire.comOPKO Health, Inc.: OPKO Health's ModeX Therapeutics Begins Clinical Trial of Tetraspecific Antibody for Treatment of B-cell LymphomasApril 24, 2026 | finanznachrichten.deModeX starts dosing in MDX2003 trial for B-cell lymphomaApril 24, 2026 | msn.comHere's Why You Should Hold OPK Stock in Your Portfolio for NowApril 23, 2026 | finance.yahoo.comHow The OPKO Health (OPK) Narrative Is Shifting After Mixed Results And A Lower Price TargetApril 23, 2026 | finance.yahoo.comOPKO Health’s ModeX Therapeutics Begins Clinical Trial of Tetraspecific Antibody for Treatment of B-cell LymphomasApril 22, 2026 | finance.yahoo.comOPKO Health's ModeX Therapeutics Begins Clinical Trial of Tetraspecific Antibody for Treatment of B-cell LymphomasApril 22, 2026 | globenewswire.comOPKO Health (OPK) to Release Earnings on WednesdayApril 22, 2026 | marketbeat.comOPKO Health to Report First Quarter 2026 Financial Results on April 28, 2026April 21, 2026 | finance.yahoo.comOPKO Health to Report First Quarter 2026 Financial Results on April 28, 2026April 21, 2026 | globenewswire.comOPKO Health, Inc. (OPK) makes progress on game-changing COVID-19 treatmentApril 15, 2026 | msn.comOPKO Health, Inc. (OPK) Makes Progress on Game changing Covid-19 TreatmentApril 14, 2026 | finance.yahoo.comOPKO Health, Inc.: OPKO Health's ModeX Therapeutics Initiates Clinical Trial of MDX2301 for the Prevention of COVID-19April 10, 2026 | finanznachrichten.deH.C. Wainwright Reaffirms Their Buy Rating on Opko Health (OPK)April 10, 2026 | theglobeandmail.comOPKO Health’s ModeX Therapeutics Initiates Clinical Trial of MDX2301 for the Prevention of COVID-19April 8, 2026 | finance.yahoo.comHow The OPKO Health (OPK) Story Is Shifting With Mixed Analyst SignalsMarch 27, 2026 | finance.yahoo.comEntera Bio Announces Full Year 2025 Financial Results and Provides Business UpdatesMarch 27, 2026 | finance.yahoo.comOPKO Health: The Waiting Game ContinuesMarch 26, 2026 | seekingalpha.comBarrington Lowers PT on OPKO Health (OPK), Keeps a BuyMarch 20, 2026 | insidermonkey.comBarrington Lowers PT on OPKO Health (OPK), Keeps a BuyMarch 20, 2026 | finance.yahoo.comOPK Q4 Earnings & Revenues Beat Estimates, Gross Margin ContractsFebruary 27, 2026 | finance.yahoo.comOPKO Health to Participate in the Jefferies Biotech on the Beach SummitFebruary 27, 2026 | globenewswire.comOPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial ResultsFebruary 26, 2026 | finance.yahoo.comOPKO Health: Q4 Earnings SnapshotFebruary 26, 2026 | finance.yahoo.com Get OPKO Health News Delivered to You Automatically Sign up to receive the latest news and ratings for OPK and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. OPK Media Mentions By Week OPK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OPK News Sentiment▼-0.380.44▲Average Medical News Sentiment OPK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OPK Articles This Week▼73▲OPK Articles Average Week Get the Latest News and Ratings for OPK and Related Stocks Enter your email address to receive the latest news and analysts' ratings for OPKO Health and its competitors. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies CLDX News Today BCRX News Today INVA News Today NVAX News Today ZBIO News Today LXRX News Today MNKD News Today GERN News Today IRWD News Today CBIO News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:OPK) was last updated on 5/22/2026 by MarketBeat.com Staff. From Our PartnersThe SpaceX supplier that shipped 5 billion chips to StarlinkWhen Nvidia surged 770%, its data center cooling supplier Vertiv climbed 1,700%. When Apple ran 2,000%, suppli...Weiss Ratings | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | Sponsored"Computers are about to become obsolete" - George Gilder. Here’s why.George Gilder predicted the iPhone 16 years early, called Netflix a decade before it dominated streaming, and ...Eagle Publishing | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredYour book attachedBill Poulos is offering his 'Simple Options Trading For Beginners' guide at no cost - normally priced at $29.9...Profits Run | SponsoredSpaceX just filed. The clock is ticking.Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...The Oxford Club | SponsoredJune 12: Elon Musk’s “Day-One Retirement Plan.”SpaceX is expected to go public on June 12 - and for the first time, everyday investors may have a way in befo...Brownstone Research | SponsoredI don't think Wall Street will warn you in timeWall Street insiders move early. Everyone else finds out later. That gap gets especially dangerous during a Ch...Trend Labs | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OPKO Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share OPKO Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
